A study of the longitudinal changes in multiple cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers on converter and non‐converter Alzheimer's disease subjects with consideration for their amyloid beta status-Reference-Cited by-同舟云学术

A study of the longitudinal changes in multiple cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers on converter and non‐converter Alzheimer's disease subjects with consideration for their amyloid beta status

Published:2022-01 Issue:1 Volume:14 Page:
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alz & Dem Diag Ass & Dis Mo

Author:

Morar Ulyana¹^ORCID,Izquierdo Walter¹,Martin Harold¹,Forouzannezhad Parisa¹,Zarafshan Elaheh¹,Unger Elona²,Bursac Zoran³,Cabrerizo Mercedes¹,Barreto Armando¹,Vaillancourt David E.⁴⁵⁶,DeKosky Steven T.⁴⁶,Loewenstein David⁶⁷,Duara Ranjan⁶⁸,Adjouadi Malek¹⁶

Affiliation:

1. Center for Advanced Technology and Education Department of Electrical and Computer Engineering Florida International University Miami Florida USA

2. College of Pharmacy Florida A&M University Tallahassee Florida USA

3. Department of Biostatistics Robert Stempel College of Public Health Florida International University Miami

4. Department of Neurology and McKnight Brain Institute College of Medicine University of Florida Gainesville Florida USA

5. Department of Applied Physiology and Kinesiology University of Florida Gainesville Florida USA

6. Florida Alzheimer's Disease Research Center (ADRC) University of Florida Gainesville Florida USA

7. Department of Psychiatry and Behavioral Sciences Miller School of Medicine University of Miami Miami Florida USA

8. Wien Center for Alzheimer's Disease and Memory Disorders Mount Sinai Medical Center Miami Florida USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dad2.12258

Reference31 articles.

1. SPECIAL REPORT on the front lines: primary care physicians and Alzheimer's care in America;Alzheimer's Disease Facts and Figures;Alzheimer's Association

2. Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease

3. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

4. Amyloid beta–positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity

5. Exploring biomarkers for Alzheimer's disease;Sharma N;J Clin Diagn Res,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSF neurogranin levels as a biomarker in Alzheimer’s disease and frontotemporal lobar degeneration: a cross-sectional analysis;Alzheimer's Research & Therapy;2024-09-06

2. Serial Cerebrospinal Fluid Sampling Reveals Trajectories of Potential Synaptic Biomarkers in Early Stages of Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-08-20

3. Associations of tau, Aβ, and brain volume of the Papez circuit with cognition in Alzheimer’s disease;European Archives of Psychiatry and Clinical Neuroscience;2024-06-02